Skip to main content

Rheological Monitoring of Chronic Respiratory Diseases

Project description

Novel point-of-care cystic fibrosis monitoring test

Chronic respiratory diseases are on the rise and becoming the third leading cause of mortality worldwide. French Rheonova is developing user-friendly monitoring based on the rheology of lung secretions. The focus of the EU-funded RheoCare project will be on cystic fibrosis as it already has organised care structures in Europe. The project's goal is to provide a dedicated plug-and-play rheometer with quantitative biomarkers and a high specificity, allowing a monitoring test within 10 minutes. Phase 1 clinical trials have demonstrated the reproducibility and the specificity of the biomarkers. The phase 2 clinical protocols are proceeding in order to demonstrate the medical benefit for patients. In addition, the company is working to develop an automated sample manipulation device that is currently at the stage of a feasibility study.

Call for proposal

H2020-SMEInst-2018-2020-1
See other projects for this call

Coordinator

RHEONOVA SAS
Address
31 Boulevard Agutte Sembat
38000 Grenoble
France
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
EU contribution
€ 50 000